DexCom's growth trend improved in 1Q25, but competition and shrinking market potential keep upside limited. Find out why DXCM ...

We recently published a list of These 10 Firms Soared Last Week, Here’s Why. In this article, we are going to take a look at ...

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...

Shares of DexCom Inc. DXCM surged 16.17% to $81.62 Friday, on what proved to be an all-around great trading session for the ...

Live Updates Live Coverage Has Ended Stocks Widen Lead 3:51 pm by Stocks have widened their lead headed into the weekend, ...

Shares of DexCom jumped over 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose monitoring devices ...

DXCM's first-quarter 2025 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by ...

Dexcom ( DXCM) was the best-performing stock in the S&P 500 when the maker of glucose monitoring devices for patients with ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...

Discover Dexcom's Q1 2025 earnings highlights, including 14% revenue growth, expanded type 2 diabetes coverage, and the upcoming launch of the 15-day ...

Investing.com -- DexCom , Inc. (NASDAQ: DXCM) saw its shares jump 3.9% after the continuous glucose monitoring (CGM) device maker reported first-quarter revenue that surpassed analyst estimates, ...

Medical device company DexCom (NASDAQ:DXCM) announced in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The ...